[Neuro-endocrine disorders in depression: their importance for the study of the pathogenesis of depression].
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D002395:Catecholamines / Q000032:analysis; D003863:Depression / Q000209:etiology* / Q000378:metabolism; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis; D007031:Hypothalamus / Q000503:physiopathology; D007328:Insulin / Q000494:pharmacology; D007980:Levodopa / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000378:metabolism; D008593:Menopause; D009490:Neurosecretory Systems / Q000503:physiopathology*; D010455:Peptides / Q000032:analysis; D010902:Pituitary Gland / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000503:physiopathology; D011388:Prolactin / Q000378:metabolism; D012701:Serotonin / Q000032:analysis; D009435:Synaptic Transmission / Q000187:drug effects; D013973:Thyrotropin-Releasing Hormone / Q000502:physiology
D002395:Catecholamines; D007328:Insulin; D010455:Peptides; D012701:Serotonin; D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D006854:Hydrocortisone
Neuro-endocriene stoornissen bij depressies; hun betekenis voor het onderzoek naar de pathogenese van depressies.